Cetera Investment Advisers
ALT icon

Cetera Investment Advisers’s Altimmune ALT Stock Holding History

Cetera Investment Advisers’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$109K Buy
35,453
+5,766
+19% +$24.5K ﹤0.01% 4427
2025
Q4 		$107K Buy
29,687
+9,481
+47% +$41.3K ﹤0.01% 4384
2025
Q3 		$76.2K Buy
20,206
+2,056
+11% +$7.94K ﹤0.01% 4374
2025
Q2 		$70.2K Sell
18,150
-4,652
-20% -$25.2K ﹤0.01% 3936
2025
Q1 		$114K Buy
22,802
+8,449
+59% +$53.5K ﹤0.01% 3749
2024
Q4 		$103K Buy
14,353
+1,270
+10% +$9.7K ﹤0.01% 3571
2024
Q3 		$80.3K Buy
13,083
+51
+0.4% +$346 ﹤0.01% 3563
2024
Q2 		$86.7K Sell
13,032
-52,304
-80% -$386K ﹤0.01% 3534
2024
Q1 		$665K Buy
+65,336
New +$665K ﹤0.01% 2387

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Cetera Investment Advisers's ALT Position: Q1 2026 in Review

Cetera Investment Advisers increased its Altimmune (ALT) stake by 19% in Q1 2026, buying an estimated $24.5K and bringing the position to 35,453 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #4427.

Cetera Investment Advisers first reported a position in ALT in Q1 2024 and has held it in 9 quarters since. The position peaked at $665K in Q1 2024. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Cetera Investment Advisers held 35,453 shares of Altimmune worth $109K as of Q1 2026.
  • Cetera Investment Advisers bought 5,766 Altimmune shares in Q1 2026, an estimated $24.5K.
  • Altimmune made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #4427 holding.
  • Cetera Investment Advisers first reported a position in Altimmune in Q1 2024 and has held it in 9 quarters since.
  • Cetera Investment Advisers's Altimmune position peaked at $665K in Q1 2024.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.